Following successful independent validation by the Liverpool School of Tropical Medicine and St George’s, University of London, Mologic, Bedford, UK, will begin manufacturing its laboratory test for covid-19. The test has also been submitted to Public Health England for formal validation.
Mologic has entered into a material transfer agreement with Omega Diagnostics, Alva, UK, which will immediately start manufacture of Mologic’s first-generation enzyme-linked immunosorbent assay (ELISA). The laboratory-based ELISA is expected to produce up to 46,000 results per day, potentially contributing a significant portion of the UK government’s planned 100,000 tests per day.
Mologic will also make the technology and materials for its test available for use in Africa through a partnership with the Institut Pasteur de Dakar, in order to support efforts to contain the pandemic on the continent.
The availability of fast, reliable tests for covid-19 has been identified as a critical opportunity to facilitate contact tracing and ‘flatten the curve’ of the global pandemic.
For more information, visit Mologic.